CAP Cancer Protocols: September 2026 Update, CAP,
Diagnosis of Iron Deficiency, ASH,
Therapeutic Apheresis in Clinical Practice, ASFA,
WHO Classification of Genetic Tumour Syndromes, WHO/IARC,
Seasonal Respiratory Virus Vaccines in Immunocompromised Patients, IDSA,
Factor Concentrates for Perioperative Bleeding, ISTH,
Primary Mediastinal B-Cell Lymphoma, BSH,
Cutaneous Toxicities of T-Cell-Redirecting Therapies in Multiple Myeloma, EADV,
Initial and Second-Line Therapy for Adult Immune Thrombocytopenia, ASH,
Major Bleeding in Emergency Patients Taking Direct Oral Anticoagulants, ACEP,
Laboratory Diagnosis and Monitoring of Thrombotic Thrombocytopenic Purpura, BSH,
Sickle Cell Disease in Pregnancy, SMFM,
Multidisciplinary Care for Bleeding and Thrombotic Disorders in Women, BSH/UKHCDO,
Diagnosis of Light Chain Amyloidosis, ASH,
International Classification of Diseases for Oncology, Fourth Edition, WHO/IARC,
Iron Deficiency and Iron Deficiency Anemia in Obstetrics and Gynecology, SOGC,
Myeloproliferative Neoplasms, NCCN,
Cell-Free DNA Screening for Fetal Red Cell Antigens, SMFM,
Direct Oral Anticoagulants for Prevention of Thrombotic Events, ACC,
Frontline Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults, ASH,
Diagnosis of Hemophilia in Women, Girls and Carriers, ISTH,
Treatment of Multiple Myeloma, ASCO,
Diagnosis, Treatment and Follow-Up of Hodgkin Lymphoma, EHA,
Iron Deficiency and Iron Deficiency Anemia in Children, AAP,
Perioperative Anemia and Blood Management in Cardiac Surgery, AHA,
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma, ASCO,
Acute Myeloid Leukemia, NCCN,
Estimation of Fetomaternal Haemorrhage, BSH,
Management of Chronic Lymphocytic Leukemia and Richter Transformation, EHA,
Anticoagulation for Cardiac Surgery in Heparin-Induced Thrombocytopenia, ISTH,
Type 2B von Willebrand Disease in Pregnancy and Postpartum, ISTH,
Preconception and Antenatal Screening for Hemoglobinopathies, EHA,
JAK Inhibitors for Inborn Errors of JAK–STAT Signalling, ESID/EBMT-IEWP/ERN-RITA,
Stem Cell Transplantation for Inborn Errors of Immunity and Metabolism, EBMT/ESID,
Early Diagnosis of Light Chain Amyloidosis, BSH,
KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKD, NKF/KDOQI,
Use of Andexanet Alfa for Factor Xa Inhibitor Reversal, BSH,
Development of Antithrombotic Drugs for Children, ISTH,
Diagnosis and Management of Severe Acquired Aplastic Anemia, ASH,
Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, NCCN,
Shared Decision-Making in Hemophilia Care, WFH/EAHAD/EHC,
White Blood Cell Growth Factors, ASCO,
2026 Guideline for Acute Pulmonary Embolism in Adults, AHA/ACC and partner societies,
Relapsed or Refractory Acute Lymphoblastic Leukemia in Adolescents and Young Adults, ASH,
Management of antithrombotic therapies in kidney transplantation candidates and recipients: an ERBP clinical practice document by the DESCaRTES Working Group of ERA and the EKITA Committee of ESOT, ERA/ERBP/ESOT,
Direct Oral Anticoagulants in Adult Cardiac Surgery, SCA/STS,
KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP), ERA/ERBP,
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD), KDIGO,
Disease Activity Score for Antiphospholipid Syndrome, EULAR,
Treatment of Systemic Lupus Erythematosus, ACR,
Diagnosis and Management of VEXAS Syndrome, ACR,
Regional Anesthesia in Patients Receiving Antithrombotic Therapy, ASRA Pain Medicine,
Perioperative Venous Thromboembolism Prophylaxis, ESAIC and partner societies,
Management of Adult and Juvenile-Onset Sjögren Disease, BSR,
Reversal of Direct Oral Anticoagulants in Life-Threatening Bleeding, ESAIC,
